Healthtech Startups

Inkblot is a digital mental health platform offering secure online video counselling for corporate mental health programs and individual counselling services in Canada. The platform matches users with qualified therapists based on their preferences and concerns.

4 investors

Online138 is an Indonesian platform offering World Cup-themed gaming experiences and a skills marketplace (SkillConnect) connecting users with local tutors, designers, tradespeople, and service providers. The platform emphasizes optimized performance across desktop and mobile devices.

4 investors

InPharmD is a medical literature research platform that analyzes published studies to answer clinical pharmacology questions, specifically focused on adverse drug reactions and medication safety.

4 investors

Insight-Med is a medtech company developing interventional cardiovascular devices, including a domestic fractional flow reserve (FFR) system approved by China's NMPA and an intravascular ultrasound (IVUS) system for precision diagnosis and treatment of cardiovascular diseases. It serves the interventional cardiology market with a portfolio spanning intravascular physiology and imaging, primarily in China.

4 investors

InsituGen develops cell-free bioassay technology for steroid hormone testing, offering a low-cost test to detect androgen and estrogen bioactivity in companion animal diagnostics. Its products include equine anti-doping and companion animal diagnostic tests, serving the animal health and diagnostics markets.

4 investors

Intact Vascular develops interventional vascular medical devices intended for use by physicians trained in interventional techniques. The company is associated with Philips.

4 investors

IntelePeer's SmartAgent provides voice, SMS, and digital AI agents that handle patient-initiated interactions such as scheduling, billing inquiries, insurance eligibility, and after-hours routing, integrated directly with EHR/EMR systems. It is built for healthcare practices, including specialty care, with a clinical check-in capability (SmartCare) for post-operative follow-up.

4 investors

Intelligent Observation provides a subscription-based hand hygiene compliance monitoring system for hospitals, using near-field magnetic induction (NFMI) smart badges and a cloud dashboard to replace manual visual observation. The system aims to reduce healthcare-acquired infections and create safer environments for patients and staff.

4 investors

Intellijoint Surgical develops surgical planning and navigation devices for orthopedic surgeons performing joint replacement procedures. The company provides technology solutions designed to improve surgical precision and patient outcomes in hip and knee replacement surgeries across North America, Australia, New Zealand, and Japan.

4 investors

Intercept Pharmaceuticals develops and commercializes treatments for rare and serious liver and other diseases, with a focus on conditions such as primary biliary cholangitis. The page displays corporate news related to Alfasigma, its parent/affiliated pharmaceutical company.

4 investors

Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.

4 investors

Intuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.

4 investors

InventisBio is a China-based drug discovery company developing patent-protected small-molecule targeted therapies for oncology and metabolic diseases. Its pipeline addresses solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as hyperuricemia/gout and autoimmune conditions like psoriasis.

4 investors

Invivox operates an online platform offering short, peer-created medical training content across multiple specialties for healthcare professionals seeking to update their knowledge. It aims to support ongoing medical education and improve patient care pathways for a global community of clinicians.

4 investors

IrisMed is an AI-powered software platform that automates insurance verification and patient cost estimation for optical practices, integrating with existing practice management systems. It helps dispensaries determine accurate patient out-of-pocket costs for lenses, coatings, and frames while identifying upsell opportunities.

4 investors

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.

4 investors

Jasper Therapeutics develops briquilimab, a targeted anti-KIT monoclonal antibody designed to deplete mast cells for treating chronic immunological and inflammatory diseases. The company is running clinical studies in chronic spontaneous urticaria, chronic inducible urticaria, and allergic asthma.

4 investors

Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers. It serves patients with high unmet medical needs in rare disease and rare cancer areas.

4 investors

A platform that connects clients with interpreters, offering competitive per-minute pricing and flexible workflow integration across devices.

4 investors

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis. The company's products are designed for interventional cardiology clinicians treating patients with structural heart disease.

4 investors

Judo Bio develops oligonucleotide medicines, including ligand-siRNA conjugate drugs, delivered to the kidney for systemic and renal diseases using its STRIKE (Selectively Targeting RNA Into KidnEy) platform. The company applies RNA-based therapeutics that harness a natural endogenous mechanism for receptor-mediated uptake by specific kidney cell types to silence disease-modifying genes.

4 investors

Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers. Its technology is used in basic research, infectious disease, oncology, and consumer genomics.

4 investors

Juno is an AI health assistant that helps people with chronic illness track symptoms, identify patterns, and create reports for medical appointments, based on university research and user feedback from over 1,000 patients.

4 investors

Juno provides disability insurance for children under 26 in the United States, offering financial protection and support to parents managing a child's severe illness or disability.

4 investors